Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Platelet rich fibrin (PRF) combined with Orabase is a novel drug delivery system that utilizes autologous platelet concentrates mixed with Orabase (a dental paste) to create a localized treatment option. This combination has been used to manage medication-related osteonecrosis of the jaw cases. PRF is a second-generation platelet concentrate sourced from the patient's own blood that contains growth factors and cytokines that promote tissue healing and regeneration. When combined with Orabase, it creates a topical application that can adhere to oral mucosa, providing sustained release of bioactive components. The combination may also be used as a carrier for antibiotics or other medications to facilitate effective release of antimicrobial agents at optimal concentrations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on platelet rich fibrin + Orabase.